{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:40:07Z","timestamp":1743864007868,"version":"3.40.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,5]]},"DOI":"10.7759\/cureus.81756","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:01:43Z","timestamp":1743861703000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperphosphatemic Familial Tumoral Calcinosis With a Large Hip Mass"],"prefix":"10.7759","author":[{"given":"Issa","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Galili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Carlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2020.03084","article-title":"A novel homozygous variant in exon 10 of the GALNT3 gene causing hyperphosphatemic familial tumoral calcinosis in a family from North India","volume":"10","author":"Dayal D","year":"2021","unstructured":"Dayal D, Gupta S, Kumar R, Srinivasan R, Lorenz-Depiereux B, Strom TM. A novel homozygous variant in exon 10 of the GALNT3 gene causing hyperphosphatemic familial tumoral calcinosis in a family from North India. Intractable Rare Dis Res. 2021, 10:55-7. 10.5582\/irdr.2020.03084","journal-title":"Intractable Rare Dis Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2005.01.002","article-title":"FGF23 and disorders of phosphate homeostasis","volume":"16","author":"Yu X","year":"2005","unstructured":"Yu X, White KE. FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev. 2005, 16:221-32. 10.1016\/j.cytogfr.2005.01.002","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0305","article-title":"The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis","volume":"91","author":"Garringer HJ","year":"2006","unstructured":"Garringer HJ, Fisher C, Larsson TE, et al.. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J Clin Endocrinol Metab. 2006, 91:4037-42. 10.1210\/jc.2006-0305","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato K","year":"2006","unstructured":"Kato K, Jeanneau C, Tarp MA, et al.. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem. 2006, 281:18370-7. 10.1074\/jbc.M602469200","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00293","article-title":"Hyperphosphatemic tumoral calcinosis: Pathogenesis, clinical presentation, and challenges in management","volume":"11","author":"Boyce AM","year":"2020","unstructured":"Boyce AM, Lee AE, Roszko KL, Gafni RI. Hyperphosphatemic tumoral calcinosis: Pathogenesis, clinical presentation, and challenges in management. Front Endocrinol (Lausanne). 2020, 11:293. 10.3389\/fendo.2020.00293","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref6","article-title":"Hyperphosphatemic familial tumoral calcinosis","author":"Ramnitz MS","year":"2018","unstructured":"Ramnitz MS, Gafni RI, Collins MT. Hyperphosphatemic familial tumoral calcinosis. GeneReviews\u00ae [Internet]. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington - Seattle, Seattle, WA; 2018."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1148\/rg.263055099","article-title":"Tumoral calcinosis: Pearls, polemics, and alternative possibilities","volume":"26","author":"Olsen KM","year":"2006","unstructured":"Olsen KM, Chew FS. Tumoral calcinosis: Pearls, polemics, and alternative possibilities. Radiographics. 2006, 26:871-85. 10.1148\/rg.263055099","journal-title":"Radiographics"},{"key":"ref8","article-title":"Familial tumoral calcinosis. A clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis","volume":"17","author":"Slavin RE","year":"1993","unstructured":"Slavin RE, Wen J, Kumar D, Evans EB. Familial tumoral calcinosis. A clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis. Am J Surg Pathol. 1993, 17:788-802.","journal-title":"Am J Surg Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2870","article-title":"Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome","volume":"31","author":"Ramnitz MS","year":"2016","unstructured":"Ramnitz MS, Gourh P, Goldbach-Mansky R, et al.. Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome. J Bone Miner Res. 2016, 31:1845-54. 10.1002\/jbmr.2870","journal-title":"J Bone Miner Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000001759","article-title":"Hyperphosphatemic familial tumoral calcinosis","volume":"117","author":"Kaszycki M","year":"2024","unstructured":"Kaszycki M, Villalpando B, Hickson L, et al.. Hyperphosphatemic familial tumoral calcinosis. South Med J. 2024, 117:705-8. 10.14423\/SMJ.0000000000001759","journal-title":"South Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-008-0775-z","article-title":"A case of familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features","volume":"20","author":"Dumitrescu CE","year":"2009","unstructured":"Dumitrescu CE, Kelly MH, Khosravi A, et al.. A case of familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. Osteoporos Int. 2009, 20:1273-8. 10.1007\/s00198-008-0775-z","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3945-z","article-title":"Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: What are the therapeutic options for a better control of phosphatemia?","volume":"33","author":"Claramunt-Taberner D","year":"2018","unstructured":"Claramunt-Taberner D, Bertholet-Thomas A, Carlier MC, Dijoud F, Chotel F, Silve C, Bacchetta J. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: What are the therapeutic options for a better control of phosphatemia?. Pediatr Nephrol. 2018, 33:1263-7. 10.1007\/s00467-018-3945-z","journal-title":"Pediatr Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1137","article-title":"Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis","volume":"152","author":"Ichikawa S","year":"2011","unstructured":"Ichikawa S, Austin AM, Gray AK, Allen MR, Econs MJ. Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis. Endocrinology. 2011, 152:4504-13. 10.1210\/en.2011-1137","journal-title":"Endocrinology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005050573","article-title":"Fibroblast growth factor 23: Roles in health and disease","volume":"16","author":"Imel EA","year":"2005","unstructured":"Imel EA, Econs MJ. Fibroblast growth factor 23: Roles in health and disease. J Am Soc Nephrol. 2005, 16:2565-75. 10.1681\/ASN.2005050573","journal-title":"J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/353528-hyperphosphatemic-familial-tumoral-calcinosis-with-a-large-hip-mass","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:01:55Z","timestamp":1743861715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/353528-hyperphosphatemic-familial-tumoral-calcinosis-with-a-large-hip-mass"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.81756","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,5]]}}}